The Law Offices of Frank R. Cruz announces an investigation of Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: ...
The DJS Law Group announces that it is investigating claims on behalf of investors of Beta Bionics, Inc. ("Beta Bionics" or ...
The downgrade comes after the Irvine-based medical device company reported preliminary fourth quarter results.
Shares of Beta Bionics fell after the maker of insulin-delivery systems shared preliminary data for new patient starts that were below expectations. The stock slipped 36%, to $20.5, on Friday. Over ...
IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...
In 2024, medtech IPOs began to come back, thanks to the likes of heart valve company Anteris Technologies and neurotech ...
Ekso Bionics (EKSO) shares nearly doubled on Dec. 30 after Applied Digital (APLD) revealed plans of spinning off its cloud ...
Beta Bionics (BBNX) reported preliminary, unaudited Q4 2025 net sales of at least $32M, compared to estimate of $28.9M, ...